SCHEMBL7423537

SCHEMBL7423537

CCCc1c(C(C)=O)c2ccc(C(=O)OC)cc2n1Cc1cc2c(cc1Cl)OCO2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
RXFP1 Q9HBX9 1/20 0.40
SLC22A12 Q96S37 1/20 0.39
EDNRA P25101 3/20 0.37
SMN1; SMN2 Q16637 5/20 0.37
TSHR P16473 4/20 0.37
LMNA P02545 4/20 0.37
GAA P10253 2/20 0.37
MAPK1 P28482 2/20 0.37
MAPT P10636 2/20 0.37
HTT P42858 2/20 0.37
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.37
USP14 P54578 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 2/20 0.36
NPC1 O15118 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7429126 0.91 MEN1 (0.40) MEN1KMT2ARXFP1SLC22A12EDNRA
SCHEMBL7424082 0.90 SLC22A12 (0.42) MEN1KMT2ASLC22A12EDNRASMN1; SMN2
SCHEMBL7426853 0.89 SLC22A12 (0.40) MEN1KMT2ASLC22A12EDNRASMN1; SMN2
SCHEMBL7419283 0.84 SMN1; SMN2 (0.41) MEN1KMT2ARXFP1SLC22A12EDNRA
SCHEMBL7425821 0.84 L3MBTL1 (0.45) MEN1KMT2ALMNAGAAMAPK1
SCHEMBL7422706 0.82 SLC22A12 (0.41) SLC22A12EDNRAMAPK1ALDH1A1
SCHEMBL7426123 0.82 SLC22A12 (0.39) MEN1KMT2ASLC22A12EDNRASMN1; SMN2
SCHEMBL7422634 0.80 L3MBTL1 (0.42) LMNAMAPK1MAPTALDH1A1
SCHEMBL7427382 0.80 SLC22A12 (0.39) MEN1KMT2ASLC22A12EDNRASMN1; SMN2
Morpholine SCHEMBL7424974 0.80 MAPT (0.40) LMNAMAPK1MAPTUSP14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed